Redusta, Efrin, SR.. D.

HRN: 03-14-97  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/28/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/28/2022
11/04/2022
IV
500 Mg
Q8H
AGE With Moderate Dehydration
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: